Ausgabe 6/2018
Inhalt (19 Artikel)
Evaluation of relative dose intensity during the early phase of first-line sunitinib treatment using a 2-week-on/1-week-off regimen for metastatic renal cell carcinoma
Kana Iwamoto, Hiroki Ishihara, Toshio Takagi, Tsunenori Kondo, Kazuhiko Yoshida, Junpei Iizuka, Kazunari Tanabe
Reduced intensity conditioning increases risk of severe cGVHD: identification of risk factors for cGVHD in a multicenter setting
Gabriel Afram, Jose Antonio Pérez Simón, Mats Remberger, Teresa Caballero-Velázquez, Rodrigo Martino, Jose Luis Piñana, Olle Ringden, Albert Esquirol, Lucia Lopez-Corral, Irene Garcia, Oriana López-Godino, Jordi Sierra, Dolores Caballero, Per Ljungman, Lourdes Vazquez, Hans Hägglund
Prognostic impact of bleomycin pulmonary toxicity on the outcomes of patients with germ cell tumors
Yuki Maruyama, Takuya Sadahira, Yosuke Mitsui, Motoo Araki, Koichiro Wada, Ryuta Tanimoto, Yasuyuki Kobayashi, Masami Watanabe, Toyohiko Watanabe, Yasutomo Nasu
Frequency of pathogenic germline mutations in cancer susceptibility genes in breast cancer patients
Raman Preet Kaur, Gowhar Shafi, Raja Paramjeet Singh Benipal, Anjana Munshi
Predictive factors for the development of irinotecan-related cholinergic syndrome using ordered logistic regression analysis
Yuko Kanbayashi, Takeshi Ishikawa, Motohiro Kanazawa, Yuki Nakajima, Yusuke Tabuchi, Rumi Kawano, Tomoko Yoshioka, Naohisa Yoshida, Toyoshi Hosokawa, Koichi Takayama, Tetsuya Taguchi
Hemoglobin level and XRCC1 polymorphisms to select patients with locally advanced rectal cancer candidate for neoadjuvant chemoradiotherapy with concurrent capecitabine and a platinum salt
Vincenzo Formica, Michaela Benassi, Giovanna Del Vecchio Blanco, Elena Doldo, Laura Martano, Ilaria Portarena, Antonella Nardecchia, Jessica Lucchetti, Cristina Morelli, Emilia Giudice, Piero Rossi, Alessandro Anselmo, Pierpaolo Sileri, Giuseppe Sica, Augusto Orlandi, Riccardo Santoni, Mario Roselli
Reclassification of risk in an emergency referral center: the need for a specific tool for the classification of onco-hematological patients. A cross-sectional study
Luciana Lopes Manfredini, Gislene Padilha dos Santos, Ana Fernanda Yamazaki Centrone, Nelson Hamerschlak
Ambient air emissions of polycyclic aromatic hydrocarbons and female breast cancer incidence in US
William Parker Stults, Yudan Wei
Effects of polymorphisms in NR1I2, CYP3A4, and ABC transporters on the steady-state plasma trough concentrations of bosutinib in Japanese patient with chronic myeloid leukemia
Maiko Abumiya, Akiko Mita, Saori Takahashi, Tomoko Yoshioka, Yoshihiro Kameoka, Naoto Takahashi, Masatomo Miura
Biomarkers defining probability of receiving second-line targeted therapy in metastatic renal cell carcinoma
Pawel Chrom, Maciej Kawecki, Rafal Stec, Lubomir Bodnar, Cezary Szczylik, Anna M. Czarnecka
Assessment of the methods used to detect HER2-positive advanced extramammary Paget’s disease
Ikuko Hirai, Keiji Tanese, Yoshio Nakamura, Atsushi Otsuka, Yasuhiro Fujisawa, Yuki Yamamoto, Hiroo Hata, Taku Fujimura, Shigeto Matsushita, Koji Yoshino, Kaori Kameyama, Masayuki Amagai, Takeru Funakoshi
Association of antibody to E2 protein of human papillomavirus and p16INK4A with progression of HPV-infected cervical lesions
Jureeporn Chuerduangphui, Chamsai Pientong, Piyawut Swangphon, Sanguanchoke Luanratanakorn, Ussanee Sangkomkamhang, Thumwadee Tungsiriwattana, Pilaiwan Kleebkaow, Ati Burassakarn, Tipaya Ekalaksananan
“Give me five” ultra-hypofractionated radiotherapy for localized prostate cancer: non-invasive ablative approach
Giulia Marvaso, Giulia Riva, Delia Ciardo, Sara Gandini, Cristiana Fodor, Dario Zerini, Sarah Pia Colangione, Giorgia Timon, Stefania Comi, Raffaella Cambria, Federica Cattani, Ottavio De Cobelli, Roberto Orecchia, Barbara A. Jereczek-Fossa
Chimeric antigen receptor T cell therapy in pancreatic cancer: from research to practice
Vishal Jindal, Ena Arora, Muhammad Masab, Sorab Gupta
Check point inhibitors a new era in renal cell carcinoma treatment
Mohamed Alsharedi, Heather Katz
Challenges and prospects of chimeric antigen receptor T cell therapy in solid tumors
Vishal Jindal, Ena Arora, Sorab Gupta
A review of HPRT and its emerging role in cancer
Michelle H. Townsend, Richard A. Robison, Kim L. O’Neill
Asymptomatic recurrence detection and cost-effectiveness in urothelial carcinoma
Hiromichi Iwamura, Shingo Hatakeyama, Makoto Sato, Chikara Ohyama
Current status of enhanced recovery after surgery (ERAS) protocol in gastrointestinal surgery
Michał Pędziwiatr, Judene Mavrikis, Jan Witowski, Alexandros Adamos, Piotr Major, Michał Nowakowski, Andrzej Budzyński